Breast Health in Obstetrics and Gynecology: A Practical Guide to Screening, Imaging, and the Symptomatic Breast-Breast Health Article

Breast Health Article

Pdf Summary

The document outlines best practices for breast health management in obstetrics and gynecology, emphasizing the clinician’s role in risk assessment, screening, symptom evaluation, and ensuring abnormal results are followed through. Breast cancer is the most common cancer in American women, so obstetrician-gynecologists are often the first to assess risk, order screening, and triage symptoms.<br /><br />For average-risk women, current guidance generally begins screening mammography at age 40, with the interval determined through shared decision-making: ACOG supports every 1 to 2 years, the USPSTF recommends every 2 years, and the ACR and American Cancer Society favor annual screening. Clinical breast self-exam is no longer routinely recommended; instead, patients should practice breast self-awareness. Clinical breast examination may be offered selectively, depending on age and shared decision-making.<br /><br />Risk should be formally assessed by age 25 to 30 using validated models. High-risk patients—such as BRCA carriers, women with strong family history, prior chest radiation, or lifetime risk of 20% or greater—should receive annual MRI plus mammography, with MRI often starting at age 25 to 30. Intermediate-risk patients may need individualized supplemental imaging. Dense breasts increase risk and reduce mammographic sensitivity, but routine extra imaging for density alone is not universally recommended.<br /><br />The guide also details symptom-based imaging. Ultrasound is first-line for palpable masses in younger women and for many pregnancy/lactation complaints; diagnostic mammography and tomosynthesis are central for women 40 and older. Pathologic nipple discharge, suspicious masses, antibiotic-refractory breast erythema, and concerning nipple or skin changes require prompt imaging and often biopsy or surgical referral. Negative imaging does not override a clinically suspicious exam.<br /><br />Finally, the article stresses closing the loop on BI-RADS results, documenting shared decisions, and maintaining referral pathways to breast imaging, surgery, oncology, and genetics.

Keywords

breast health

obstetrics and gynecology

breast cancer screening

mammography

risk assessment

breast self-awareness

high-risk patients

breast ultrasound

BI-RADS

shared decision-making